DepoMed Inc. (DEPO) 4Q Beats Expectations

DepoMed Inc. (DEPO) shares are up $0.65 to $21.15 in after-hours trading Monday after the company reported its fourth quarter earnings results. The Newark, Calif.-based pharmaceutical firm reported earnings of $0.21 per share on revenues of $194.6 million, up 379.20% from a year ago. Analysts were expecting EPS of $0.07 on revenues of $43.24 million. […] View the full post at: DepoMed Inc. (DEPO) 4Q Beats Expectations Related posts: Insider Selling: Twitter (TWTR) CEO Unloads $5M Worth of Stock